HOME >> MEDICINE >> NEWS
Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression

ATLANTA, US; LONDON, UK -- Through a unique partnership among academia, industry, and government, a team of scientists from Emory University School of Medicine, GlaxoSmithKine (GSK), and the National Institute of Mental Health (NIMH) will work together to accelerate the development of drugs to treat depression and other mood disorders. The new venture, funded through a $4.9 million, five-year grant from the National Institutes of Health, is one of three new national NIH (NIMH and NIDA)-supported National Cooperative Drug Discovery Groups.

The "Emory-GSK-NIMH Collaborative Mood Disorders Initiative" will join the expertise of three complementary research groups: the Emory University School of Medicine Department of Psychiatry and Behavioral Sciences, the Mood and Anxiety Disorders Program at NIMH, and the Center for Excellence for Drug Discovery in Psychiatry at GlaxoSmithKline. The two major goals of the new venture will be the development of innovative new models for basic and clinical research in mood disorders, and the intensive scrutiny of novel GSK antidepressant candidates in pre-clinical and clinical studies.

Scientists at NIMH's own laboratories in Bethesda, MD, led by Dennis S. Charney, MD, will develop clinical models to assess novel antidepressants. Emory School of Medicine faculty including Michael Davis, PhD, Robert Woodruff professor of psychiatry and behavioral sciences and Andrew H. Miller, MD, professor of psychiatry and behavioral sciences, will develop preclinical models of fear, anxiety, and depression. In collaboration with scientists at GSK, they will test novel antidepressant candidates already under development by the pharmaceutical company as well as newly discovered candidates.

"By joining Emory's longstanding and groundbreaking research programs in depression and mood disorders with the highly successful programs at NIMH and the novel drug development program at GlaxoSmithKline, we hope to better ser
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
1-Dec-2003


Page: 1 2

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Advertising by academic medical centers may risk eroding public trust, says study
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. NJIT taps into solar energy to power new campus center
5. Multi-center study shows direct link between residential radon exposure and lung cancer
6. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
7. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
8. Surgeon General at Childrens Hospital & Research Center at Oakland
9. Leadership gift from Sulpizio Family for new state-of-the-art cardiovascular center at UCSD
10. Yale opens Center for Interdisciplinary Research on AIDS (CIRA) in India
11. Dedicated hospital stroke centers improve quality of acute care

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is ... Psychology . , Among the first of its kind in the nation, ...
(Date:8/31/2020)... ... ... for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in ... deep anxiety, immense stress, and right now are needing serious relief from a constant state ... planet are experiencing a great degree of emotional discomfort, be it fear or worrying about ...
(Date:8/31/2020)... HAVEN, Conn. (PRWEB) , ... August 31, 2020 ... ... medical device intended to improve outcomes for patients with advanced heart failure, today ... Research (SBIR) grant in the amount of $555,358 from the National Heart, Lung, ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... system designed to help treat patients with respiratory conditions, including COVID-19, while reducing ... helium and oxygen, but it captures exhaled gas and scrubs it free of ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True North ... Biodefense Indoor Air Protection System that is the first system designed and proven to ... with the filtration system on September 8th. , The IVP Air S1 model ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... MYERS, Fla. (PRWEB) , ... August 27, 2020 , ... ... Board of Directors. Dr. Friedman is an adult and pediatric neuro-oncologist who serves on ... University and as an educator at Duke University Medical School. , Internationally recognized, Dr. ...
(Date:8/26/2020)... ... , ... AseptiScope, a privately funded San Diego, California based, clinical innovation company, ... , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, AseptiScope ... their hands, goggles on their eyes, covers on their shoes, and gowns on their ...
(Date:8/26/2020)... (PRWEB) , ... August 26, ... ... Holdings company today announced that it has entered into definitive agreement to ... CME/CE, primarily focused on pharmacists and pharmacy technicians. , CEA represents ...
Breaking Medicine Technology:
Cached News: